On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-L-tryptophan in conscious rats

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 8, 1996, Pages 825-828

  Li, Xi Ming ^a   Perry, Kenneth W ^a   Fuller, Ray W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FLUOXETINE; PERGOLIDE; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; MALE; MICRODIALYSIS; NEOSTRIATUM; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029789015     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03982.x     Document Type: Article

References (22)

1. Benloucif, S., Galloway, M. P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200: 1-8
2. Bonanno, G., Fassio, A., Severi, P., Ruelle, A., Raiteri, M. (1994) Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63: 1163-1166
3. DeMontis, G. M., Devoto, P., Gessa, G. L., Meloni, D., Porcella, A., Saba, P., Serra, G., Tagliamonte, A. (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur. J. Pharmacol. 180:31-37
4. Fuller, R. W. (1991) Role of serotonin in therapy of depression and related disorders. J. Clin. Psychiatry 52 (Suppl): 52-57
5. Fuller, R. W. (1992) Clinical applications of 5-HT uptake inhibitors. In: Advances in the Biosciences, Volume 85, Serotonin, CNS Receptors and Brain Function, pp 255-270
6. Fuller, R. W., Perry, K. W., Molloy, B. B. (1974) Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 15: 1161-1171
7. Fuller, R. W., Snoddy, H. D., Robertson, D. W. (1988) Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol. Biochem. Behav. 30: 715-721
8. Herve, D., Pickel, V. M., Joh, T. H., Beaudet, A. (1987) Serotonin axon terminals in the ventral tegmental area of the rat. Fine structure and synaptic input to dopaminergic neurons. Brain Res. 435: 71-80
9. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT: a microdialysis study. J. Neurochem. 60: 776-779
10. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260: 251-255
11. Ichikawa, J., Meltzer, H. Y. (1995) Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur. J. Pharmacol. 281: 255-261
12. Jimerson, D. C. (1987) Role of dopamine mechanisms in the affective disorders. In: Meltzer, H. Y. (ed.) Psychophamacology: The Third Generation of Progress, Raven Press, New York, pp 505-519
13. Nedergaard, S., Bolam, J. P., Greenfield, S. A. (1988) Facilitation of a dendritic calcium conductance by 5-HT in the substantia nigra. Nature 333: 174-177
14. Paxinos, G., Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego
15. Perry, K. W., Fuller, R. W. (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50: 1683-1690
16. Perry, K. W., Fuller, R. W. (1993) Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J. Pharm. Pharmacol. 45: 759-761
17. Rutter, J. J., Auerbach, S. B. (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265: 1319-1324
18. Sabol, K. E., Richards, J. B., Seiden, L. S. (1992) Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585: 421-424
19. 3 receptor antagonist, on A9 and A10 dopamine neurons. Eur. J. Pharmacol. 163: 115-120
20. Wilner, P. (1983) Dopamine and depression: a review of recent evidence. Brain Res. Rev. 6: 211-227
21. Winer, B. J. (1971) Statistical Principles in Experimental Design. McGraw-Hill, New York
22. Wong, D. T., Horng, J. S., Bymaster, F. P., Hauser, K. L., Molloy, B. B. (1974) A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)N-methyl-3-phenylpropylamine. Life Sci. 15: 471-479